Neirg Wealth Management, LLC Eli Lilly & CO Transaction History

Neirg Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $239,555 - $320,313	-683 Reduced 10.67%	5,720 $2.68 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $8,076 - $9,485	-26 Reduced 0.4%	6,403 $2.2 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $36,013 - $41,963	-112 Reduced 1.71%	6,429 $2.35 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $172,254 - $196,302	-581 Reduced 8.16%	6,541 $2.12 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $2.05 Million - $2.4 Million	-7,339 Reduced 50.75%	7,122 $2.31 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $111,947 - $139,121	-477 Reduced 3.19%	14,461 $4.14 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $3.36 Million - $4.17 Million	14,938 New	14,938 $4.13 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Neirg Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Neirg Wealth Management, LLC with notifications on news.